Metaclipse Therapeutics
This company is developing novel personalized vaccine immunotherapies for cancer.
Date | Investors | Amount | Round |
---|---|---|---|
$30.0k | Grant | ||
$30.0k | Grant | ||
$40.0k | Grant | ||
$2.4m | Grant | ||
N/A | $1.0m | Seed | |
Total Funding | $3.5m |
Recent News about Metaclipse Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.